Table 1 The clinical data of the patients with PTC
From: LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis
Variable | CALML3-AS1 expression | P value | |
|---|---|---|---|
|  | High (n = 26) | Low (n = 26) |  |
Age | |||
 < 55 | 15 | 12 | 0.405 |
 ≥55 | 11 | 14 |  |
Gender | |||
 Male | 13 | 17 | 0.262 |
 Female | 13 | 9 |  |
Extra thyroidal extension | |||
 Negative | 16 | 15 | 0.777 |
 Positive | 10 | 11 |  |
Tumor size (cm) | |||
 ≤1 | 17 | 6 | 0.002* |
 > 1 | 9 | 20 |  |
TNM stage | |||
 I/II | 21 | 19 | 0.510 |
 III/IV | 5 | 7 |  |
Lymph node metastasis | |||
 Negative | 18 | 10 | 0.026* |
 Positive | 8 | 16 |  |